News

Filter

Current filters:

Licensing

51 to 60 of 96601 results

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

22-10-2014

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance…

BiotechnologyGastro-intestinalsImmune PharmaceuticalsIsraelResearchUSA

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

22-10-2014

Clinical-stage oncology biotech company PhosImmune has entered into a license and collaboration agreement…

BiotechnologyLicensingOncologyPhosImmunePureMHCUSA

Kamada says study supports alpha-1 antitrypsin Glassia for type-1 diabetes

22-10-2014

Israeli biopharma company Kamada says that a comprehensive review of the data available in the literature…

BiotechnologyDiabetesGlassiaKamadaResearch

NICE recommends another new skin cancer drug, GSK’s Tafinlar

22-10-2014

The UK National Institute for Health and Care Excellence (NICE) has issued final guidance recommending…

GlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTafinlarUK

Karus appoints Simon Roitt and Peter Finan

Karus appoints Simon Roitt and Peter Finan

21-10-2014

UK-based inflammatory disease and cancer specialist Karus Therapeutics has appointed Simon Roitt as head…

BoardroomKarusKarus TherapeuticsNovartisUK

IQWiG finds no added benefit for GSK’s Anoro Ellipta in COPD

21-10-2014

According to the findings of an early benefit assessment under the German Act on the Reform of the Market…

Anoro ElliptaGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationRespiratory and Pulmonary

MorphoSys gets milestone from Novartis; acquires new technology

21-10-2014

German company MorphoSys says it has received a milestone payment from Novartis in connection with the…

BiotechnologyLanthio PharmalanthipeptideMergers & AcquisitionsMorphoSysNovartisOphthalmicsResearch

Reckitt Benckiser Pharmaceuticals demerges from group and rebrands as Indivior

Reckitt Benckiser Pharmaceuticals demerges from group and rebrands as Indivior

21-10-2014

US-based pharma company Reckitt Benckiser Pharmaceuticals announced that its UK-based parent company,…

Business FinancePharmaceuticalReckitt BenckiserReckitt Benckiser PharmaceuticalsUSA

51 to 60 of 96601 results

Back to top